We are uniting senior experts and young scientists from biology, biophysics, and engineering.
Our interdisciplinary team of bioengineers, physicians, pharmacologists, and toxicologists combines scientific precision with entrepreneurial spirit. Guided by principles of physics and quantum biochemistry, we turn complex ideas into scalable, production-ready technologies — from concept to global impact.
ICHORtec GmbH originated as a spin-off from IEM, known for advances in cardiovascular diagnostics and long-term blood pressure monitoring.
Seeking to understand cardiovascular dynamics, the team recognized that many phenomena could be better explained by quantum physics rather than classical mechanics — leading to the founding of ICHORtec to bridge quantum principles with molecular science.
Supported by family investors, ICHORtec created its first patents and IP portfolio, later establishing a laboratory infrastructure in Berlin funded by EFRE and IBB programs. These steps enabled rapid progress from TRL 4 to 7, partnerships with universities and clinical institutions, and the first international publications validating the platform’s potential.
